| Literature DB >> 29985171 |
Didier Dulon1,2, Samantha Papal1,3,4, Pranav Patni1,3,4, Matteo Cortese1,3,4, Philippe Fy Vincent1,2, Margot Tertrais1,2, Alice Emptoz1,3,4, Abdelaziz Tlili1,3,4, Yohan Bouleau1,2, Vincent Michel1,3,4, Sedigheh Delmaghani1,3,4, Alain Aghaie1,3,4, Elise Pepermans1,3,4, Olinda Alegria-Prevot1,3,4, Omar Akil5, Lawrence Lustig6, Paul Avan7, Saaid Safieddine1,3,4,8, Christine Petit1,3,4,9, Aziz El-Amraoui1,3,4.
Abstract
Clarin-1, a tetraspan-like membrane protein defective in Usher syndrome type IIIA (USH3A), is essential for hair bundle morphogenesis in auditory hair cells. We report a new synaptic role for clarin-1 in mouse auditory hair cells elucidated by characterization of Clrn1 total (Clrn1ex4-/-) and postnatal hair cell-specific conditional (Clrn1ex4fl/fl Myo15-Cre+/-) knockout mice. Clrn1ex4-/- mice were profoundly deaf, whereas Clrn1ex4fl/fl Myo15-Cre+/- mice displayed progressive increases in hearing thresholds, with, initially, normal otoacoustic emissions and hair bundle morphology. Inner hair cell (IHC) patch-clamp recordings for the 2 mutant mice revealed defective exocytosis and a disorganization of synaptic F-actin and CaV1.3 Ca2+ channels, indicative of a synaptopathy. Postsynaptic defects were also observed, with an abnormally broad distribution of AMPA receptors associated with a loss of afferent dendrites and defective electrically evoked auditory brainstem responses. Protein-protein interaction assays revealed interactions between clarin-1 and the synaptic CaV1.3 Ca2+ channel complex via the Cavβ2 auxiliary subunit and the PDZ domain-containing protein harmonin (defective in Usher syndrome type IC). Cochlear gene therapy in vivo, through adeno-associated virus-mediated Clrn1 transfer into hair cells, prevented the synaptic defects and durably improved hearing in Clrn1ex4fl/fl Myo15-Cre+/- mice. Our results identify clarin-1 as a key organizer of IHC ribbon synapses, and suggest new treatment possibilities for USH3A patients.Entities:
Keywords: Calcium channels; Gene therapy; Neuroscience; Synapses
Mesh:
Substances:
Year: 2018 PMID: 29985171 PMCID: PMC6063508 DOI: 10.1172/JCI94351
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808